BRAF/MEK inhibitors
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BRAF/MEK inhibitors, covering 2023-03-14 to 2023-03-14. Get the full timeline:
Most recent: Clinical Trial Update: (Neo)Adjuvant BRAF/MEK Inhibition in pN1c Melanoma [Phase 2]